Close Menu

NEW YORK – Roche announced Friday that its Cobas SARS-CoV-2 & Influenza A/B test received Emergency Use Authorization from the US Food and Drug Administration. 

The RT-PCR test runs on Roche's Cobas 6800/8800 systems and is intended to qualitatively detect and differentiate SARS-CoV-2, influenza A, and influenza B from one nasal or nasopharyngeal sample. The multiplex test is also available in countries accepting the CE mark.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Springer Nature announces €9,500 fee to make papers open-access in Nature and its family of journals.

An early SARS-CoV-2 alteration may have enabled it to spread more easily, according to the New York Times.

Librarians have concluded that notebooks that belonged to Charles Darwin that were thought to have been lost were actually likely stolen, CNN reports.

In PNAS this week: ultrarare variants contribute to aging-related hearing loss, telomeres of cells infected with herpesvirus, and more.